Postoperative hyperkalemia is an important complication of adrenalectomy for aldosterone-producing adenoma. Recently, postoperative hyperkalemia has been found to have a relatively high incidence ...
Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...
Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window As explained by ...
G_hyperkalemia_web How much do your patients know about the dangers of high potassium levels in the body? They may know that potassium is good for you, or that you need specific levels of it in the ...
Hyperkalemia is an abnormally high level of potassium in the blood. The normal level of serum potassium (potassium in the fluid portion of the blood) is 3.5 to 5.0 mmol/l. When serum potassium is ...
While many healthcare professionals understand the danger of kidney disease, and how critical the organs are in our everyday lives, few understand one of the serious conditions that often occurs when ...
October 8, 2009 (UPDATED October 23, 2009) — Angiotensin-converting enzyme inhibitors (ACEIs) are more likely than other antihypertensive drugs to cause hyperkalemia, according to the results of a ...
Please provide your email address to receive an email when new articles are posted on . The National Kidney Foundation launched a public education video series about hyperkalemia for patients with ...
Treatment with angiotensin-converting enzyme inhibitors was most strongly associated with hyperkalemia. Hyperkalemia commonly occurs among outpatients, and certain classes of antihypertensive ...
Please provide your email address to receive an email when new articles are posted on . Overall, 38 patients had hyperkalemia before dialysis, researchers found. A daily intake of greater than 15.33 g ...
For patients with heart failure with reduced ejection fraction (HFrEF), the addition of dapagliflozin (Farxiga) to a mineralocorticoid receptor antagonist (MRA) halved the incidence of moderate to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results